Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia.
Abeykoon JP, Zanwar S, Ansell SM, Muchtar E, He R, Greipp PT, King RL, Ailawadhi S, Paludo J, Larsen JT, Habermann TM, Inwards D, Go RS, Thanarajasingam G, Buadi F, Dispenzieri A, Thompson CA, Witzig TE, Lacy M, Gonsalves W, Nowakowski GS, Dingli D, Rajkumar SV, Kyle RA, Sher T, Roy V, Rosenthal A, Chanan-Khan AA, Reeder C, Gertz MA, Kumar S, Kapoor P.
Abeykoon JP, et al. Among authors: rosenthal a.
Am J Hematol. 2021 Aug 1;96(8):945-953. doi: 10.1002/ajh.26210. Epub 2021 May 22.
Am J Hematol. 2021.
PMID: 33909933
Free article.